Simeon George - Net Worth and Insider Trading
Simeon George Net Worth
The estimated net worth of Simeon George is at least $698 Million dollars as of 2024-05-26. Simeon George is the Director of Principia Biopharma Inc and owns about 2,982,855 shares of Principia Biopharma Inc (PRNB) stock worth over $298 Million. Simeon George is the Director of CRISPR Therapeutics AG and owns about 3,220,627 shares of CRISPR Therapeutics AG (CRSP) stock worth over $178 Million. Simeon George is also the Director of Turning Point Therapeutics Inc and owns about 2,253,660 shares of Turning Point Therapeutics Inc (TPTX) stock worth over $171 Million. Besides these, Simeon George also holds Design Therapeutics Inc (DSGN) , Nkarta Inc (NKTX) . Details can be seen in Simeon George's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Simeon George has not made any transactions after 2024-03-27 and currently still holds the listed stock(s).
Transaction Summary of Simeon George
Simeon George Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Simeon George owns 10 companies in total, including Principia Biopharma Inc (PRNB) , Nkarta Inc (NKTX) , and Turning Point Therapeutics Inc (TPTX) among others .
Click here to see the complete history of Simeon George’s form 4 insider trades.
Insider Ownership Summary of Simeon George
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| PRNB | Principia Biopharma Inc | 2020-09-28 | director |
| NKTX | Nkarta Inc | 2024-03-27 | director |
| TPTX | Turning Point Therapeutics Inc | 2020-05-21 | director |
 | | 2016-10-24 | director |
| | 2015-05-05 | director |
| | 2014-02-04 | director |
| | 2022-02-03 | 10 percent owner |
| | 2022-12-20 | director & 10 percent owner |
| | 2021-08-25 | 10 percent owner |
| | 2014-02-04 | director |
Simeon George Latest Holdings Summary
Simeon George currently owns a total of 5 stocks. Among these stocks, Simeon George owns 2,982,855 shares of Principia Biopharma Inc (PRNB) as of October 18, 2019, with a value of $298 Million and a weighting of 42.78%. Simeon George owns 3,220,627 shares of CRISPR Therapeutics AG (CRSP) as of October 24, 2016, with a value of $178 Million and a weighting of 25.5%. Simeon George also owns 2,253,660 shares of Turning Point Therapeutics Inc (TPTX) as of May 21, 2020, with a value of $171 Million and a weighting of 24.56%. The other 2 stocks Design Therapeutics Inc (DSGN) , Nkarta Inc (NKTX) have a combined weighting of 7.16% among all his current holdings.
Latest Holdings of Simeon George
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| PRNB | Principia Biopharma Inc | 2019-10-18 | 2,982,855 | 100.05 | 298,434,643 |
| CRSP | CRISPR Therapeutics AG | 2016-10-24 | 3,220,627 | 55.24 | 177,907,435 |
| TPTX | Turning Point Therapeutics Inc | 2020-05-21 | 2,253,660 | 76.01 | 171,300,697 |
| DSGN | Design Therapeutics Inc | 2022-12-20 | 6,526,476 | 4.36 | 28,455,435 |
| NKTX | Nkarta Inc | 2024-03-27 | 3,333,333 | 6.44 | 21,466,665 |
Holding Weightings of Simeon George
Simeon George Form 4 Trading Tracker
According to the SEC Form 4 filings, Simeon George has made a total of 1 transactions in Principia Biopharma Inc (PRNB) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Principia Biopharma Inc is the acquisition of 357,142 shares on October 18, 2019, which cost Simeon George around $10 Million.
According to the SEC Form 4 filings, Simeon George has made a total of 0 transactions in CRISPR Therapeutics AG (CRSP) over the past 5 years. The most-recent trade in CRISPR Therapeutics AG is the acquisition of 66,500 shares on October 24, 2016, which cost Simeon George around $931,000.
According to the SEC Form 4 filings, Simeon George has made a total of 2 transactions in Turning Point Therapeutics Inc (TPTX) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Turning Point Therapeutics Inc is the acquisition of 83,333 shares on May 21, 2020, which cost Simeon George around $5 Million.
More details on Simeon George's insider transactions can be found in the Insider Trading History of Simeon George table.Insider Trading History of Simeon George
- 1
Simeon George Trading Performance
GuruFocus tracks the stock performance after each of Simeon George's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Simeon George is 16.86%. GuruFocus also compares Simeon George's trading performance to market benchmark return within the same time period. The performance of stocks bought by Simeon George within 3 months outperforms 6 times out of 9 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Simeon George's insider trading performs compared to the benchmark.
Performance of Simeon George
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -1.18 | | | | | |
| Relative Return to S&P 500(%) | -1.97 | | | | | |
Simeon George Ownership Network
Simeon George Owned Company Details
What does Principia Biopharma Inc do?
Who are the key executives at Principia Biopharma Inc?
Simeon George is the director of Principia Biopharma Inc. Other key executives at Principia Biopharma Inc include Chief Medical Officer Dolca Thomas , Chief Development Officer Stefani Wolff , and Chief Scientific Officer David M Goldstein .
Principia Biopharma Inc (PRNB) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Principia Biopharma Inc (PRNB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Principia Biopharma Inc (PRNB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Principia Biopharma Inc (PRNB)'s detailed insider trading history can be found in Insider Trading Tracker table.
Principia Biopharma Inc Insider Transactions
Simeon George Mailing Address
Above is the net worth, insider trading, and ownership report for Simeon George. You might contact Simeon George via mailing address: 161 Washington Street, Suite 500, Conshohocken Pa 19428.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
